Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T17:57:53.359Z.
Calculation as of: 2026-10-06T17:57:53.359Z.
Quote observation: 2026-10-06T17:55:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2d10fe3d61b0e44c4972ff3bdbdc4638c39be0bdbd34ced4654fb4b6b9e88730
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-08-08.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$412.21M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Prothena Corporation plc (PRTA) | $424.06M | N/A | N/A | N/A | N/A |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $422.94M | N/A | N/A | N/A | N/A |
| Tilray Brands, Inc. (TLRY)vs › | $425.52M | N/A | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $429.88M | N/A | 64.08x | 60.43x | 132.37x |
| Editas Medicine, Inc. (EDIT)vs › | $430.34M | N/A | N/A | N/A | N/A |
| Tectonic Therapeutic, Inc. (TECX)vs › | $432.52M | N/A | N/A | N/A | N/A |
| Assembly Biosciences, Inc. (ASMB)vs › | $433.90M | N/A | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $413.34M | N/A | N/A | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $412.21M | N/A | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $411.47M | N/A | 135.39x | 60.74x | 42.42x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2022-08-08 | 15.26x |
| 2022-08-05 | 15.34x |
| 2022-08-04 | 14.73x |
| 2022-08-03 | 13.79x |
| 2022-08-02 | 12.96x |
| 2022-08-01 | 12.93x |
| 2022-07-29 | 13.89x |
| 2022-07-28 | 14.36x |
| 2022-07-27 | 14.45x |
| 2022-07-26 | 13.85x |
| 2022-07-25 | 13.76x |
| 2022-07-22 | 13.85x |
| 2022-07-21 | 15.16x |
| 2022-07-20 | 14.93x |
| 2022-07-19 | 14.09x |
| 2022-07-18 | 13.14x |
| 2022-07-15 | 13.64x |
| 2022-07-14 | 13.49x |
| 2022-07-13 | 13.48x |
| 2022-07-12 | 13.24x |
| 2022-07-11 | 13.11x |
| 2022-07-08 | 14.19x |
| 2022-07-07 | 13.65x |
| 2022-07-06 | 12.86x |
| 2022-07-05 | 12.92x |
| 2022-07-01 | 11.65x |
| 2022-06-30 | 11.13x |
| 2022-06-29 | 10.89x |
| 2022-06-28 | 10.86x |
| 2022-06-27 | 11.45x |
| 2022-06-24 | 11.56x |
| 2022-06-23 | 11.40x |
| 2022-06-22 | 10.27x |
| 2022-06-21 | 10.02x |
| 2022-06-17 | 8.81x |
| 2022-06-16 | 8.10x |
| 2022-06-15 | 8.68x |
| 2022-06-14 | 8.15x |
| 2022-06-13 | 8.01x |
| 2022-06-10 | 9.32x |
| 2022-06-09 | 10.96x |
| 2022-06-08 | 11.83x |
| 2022-06-07 | 12.04x |
| 2022-06-06 | 10.46x |
| 2022-06-03 | 11.37x |
| 2022-06-02 | 10.82x |
| 2022-06-01 | 10.68x |
| 2022-05-31 | 11.18x |
| 2022-05-27 | 11.86x |
| 2022-05-26 | 10.74x |
| 2022-05-25 | 10.14x |
| 2022-05-24 | 10.28x |
| 2022-05-23 | 10.62x |
| 2022-05-20 | 11.08x |
| 2022-05-19 | 10.46x |
| 2022-05-18 | 10.03x |
| 2022-05-17 | 11.69x |
| 2022-05-16 | 10.32x |
| 2022-05-13 | 10.53x |
| 2022-05-12 | 9.33x |
| 2022-05-11 | 9.54x |
| 2022-05-10 | 11.00x |
| 2022-05-09 | 11.06x |
| 2022-05-06 | 12.99x |
| 2022-05-05 | 10.92x |
| 2022-05-04 | 12.37x |
| 2022-05-03 | 11.41x |
| 2022-05-02 | 11.96x |
| 2022-04-29 | 11.01x |
| 2022-04-28 | 11.54x |
| 2022-04-27 | 9.70x |
| 2022-04-26 | 10.64x |
| 2022-04-25 | 13.66x |
| 2022-04-22 | 13.71x |
| 2022-04-21 | 14.70x |
| 2022-04-20 | 15.30x |
| 2022-04-19 | 14.76x |
| 2022-04-18 | 14.05x |
| 2022-04-14 | 15.54x |
| 2022-04-13 | 16.41x |
| 2022-04-12 | 15.07x |
| 2022-04-11 | 14.43x |
| 2022-04-08 | 15.80x |
| 2022-04-07 | 16.54x |
| 2022-04-06 | 17.13x |
| 2022-04-05 | 16.71x |
| 2022-04-04 | 18.02x |
| 2022-04-01 | 17.42x |
| 2022-03-31 | 15.81x |
| 2022-03-30 | 15.78x |
| 2022-03-29 | 16.85x |
| 2022-03-28 | 16.06x |
| 2022-03-25 | 16.06x |
| 2022-03-24 | 16.63x |
| 2022-03-23 | 15.64x |
| 2022-03-22 | 16.58x |
| 2022-03-21 | 16.52x |
| 2022-03-18 | 17.49x |
| 2022-03-17 | 16.23x |
| 2022-03-16 | 15.25x |
| 2022-03-15 | 13.71x |
| 2022-03-14 | 12.81x |
| 2022-03-11 | 13.78x |
| 2022-03-10 | 14.15x |
| 2022-03-09 | 14.15x |
| 2022-03-08 | 12.02x |
| 2022-03-07 | 11.73x |
| 2022-03-04 | 11.95x |
| 2022-03-03 | 13.10x |
| 2022-03-02 | 13.78x |
| 2022-03-01 | 13.77x |
| 2022-02-28 | 14.54x |
| 2022-02-25 | 16.35x |
| 2022-02-24 | 15.84x |
| 2022-02-23 | 14.38x |
| 2022-02-22 | 15.55x |
| 2022-02-18 | 15.22x |
| 2022-02-17 | 16.17x |
| 2022-02-16 | 17.68x |
| 2022-02-15 | 17.82x |
| 2022-02-14 | 16.44x |
| 2022-02-11 | 16.48x |
| 2022-02-10 | 16.80x |
| 2022-02-09 | 17.26x |
| 2022-02-08 | 15.99x |
| 2022-02-07 | 15.93x |
| 2022-02-04 | 15.25x |
| 2022-02-03 | 14.32x |
| 2022-02-02 | 14.57x |
| 2022-02-01 | 15.90x |
| 2022-01-31 | 15.50x |
| 2022-01-28 | 14.55x |
| 2022-01-27 | 13.70x |
| 2022-01-26 | 15.26x |
| 2022-01-25 | 15.66x |
| 2022-01-24 | 16.45x |
| 2022-01-21 | 16.29x |
| 2022-01-20 | 16.42x |
| 2022-01-19 | 16.90x |
| 2022-01-18 | 17.51x |
| 2022-01-14 | 19.23x |
| 2022-01-13 | 17.66x |
| 2022-01-12 | 17.82x |
| 2022-01-11 | 21.01x |
| 2022-01-10 | 20.83x |
| 2022-01-07 | 20.37x |
| 2022-01-06 | 22.05x |
| 2022-01-05 | 22.79x |
| 2022-01-04 | 24.23x |
| 2022-01-03 | 25.87x |
| 2021-12-31 | 25.99x |
| 2021-12-30 | 24.84x |
| 2021-12-29 | 24.23x |
| 2021-12-28 | 23.46x |
| 2021-12-27 | 24.64x |
| 2021-12-23 | 25.30x |
| 2021-12-22 | 24.40x |
| 2021-12-21 | 24.37x |
| 2021-12-20 | 23.94x |
| 2021-12-17 | 24.34x |
| 2021-12-16 | 21.85x |
| 2021-12-15 | 23.09x |
| 2021-12-14 | 21.00x |
| 2021-12-13 | 22.41x |
| 2021-12-10 | 22.09x |
| 2021-12-09 | 22.98x |
| 2021-12-08 | 26.10x |
| 2021-12-07 | 25.97x |
| 2021-12-06 | 22.34x |
| 2021-12-03 | 24.07x |
| 2021-12-02 | 26.18x |
| 2021-12-01 | 24.11x |
| 2021-11-30 | 26.51x |
| 2021-11-29 | 25.87x |
| 2021-11-26 | 25.82x |
| 2021-11-24 | 28.90x |
| 2021-11-23 | 27.20x |
| 2021-11-22 | 32.57x |
| 2021-11-19 | 32.38x |
| 2021-11-18 | 29.55x |
| 2021-11-17 | 30.86x |
| 2021-11-16 | 30.35x |
| 2021-11-15 | 31.33x |
| 2021-11-12 | 31.33x |
| 2021-11-11 | 30.86x |
| 2021-11-10 | 30.57x |
| 2021-11-09 | 30.88x |
| 2021-11-08 | 32.24x |
| 2021-11-05 | 32.53x |
